{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:45:11Z","timestamp":1790840711229,"version":"4.1.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":321,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR069655"],"award-info":[{"award-number":["P30 AR069655"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG049994"],"award-info":[{"award-number":["R01AG049994"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008091","name":"University of Rochester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR069655"],"award-info":[{"award-number":["P30 AR069655"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG049994"],"award-info":[{"award-number":["R01AG049994"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008091","name":"University of Rochester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The risk of osteoporosis is increased in rheumatoid arthritis (RA). Anti-tumor necrosis factor (TNF) therapy has markedly improved the outcomes of RA patients but does not improve osteoporosis in some reports. This could be a combined result of disease severity and other therapeutic agents, such as glucocorticoids that accelerate osteoporosis progression. We evaluated the effects of anti-TNF therapy on osteoporosis in an animal model of RA and explored the possible mechanisms involved. Six-week-old TNF transgenic (TNF-Tg) mice with early stage erosive arthritis were treated with TNF antibody (Ab) or control immunoglobulin (IgG) weekly for 4\u2009weeks. We found that TNF Ab completely blocked the development of erosive arthritis in TNF-Tg mice, but only slightly increased vertebral bone mass, associated with reduction in parameters of both bone resorption and formation. Similarly, TNF Ab slightly increased trabecular bone mass in tibias of 8-month-old TNF-Tg mice with advanced erosive arthritis. Interestingly, TNF\u03b1 increased osteoblast differentiation from mouse bone marrow stromal cells (BMSCs) containing large number of macrophages but not from pure mesenchymal progenitor cells (MPCs). TNF\u03b1-polarized macrophages (TPMs) did not express iNos and Arginase 1, typical markers of inflammatory and resident macrophages. Interestingly, TPMs stimulated osteoblast differentiation, unlike resident and inflammatory macrophages polarized by IL-4 and interferon-\u03bb, respectively. RNA-seq analysis indicated that TPMs produced several anabolic factors, including Jagged1 and insulin like 6 (INSL6). Importantly, inhibition of either Jagged1 or INSL6 blocked TNF\u03b1-induced osteoblast differentiation. Furthermore, INSL6 Ab significantly decreased the expansion of TNF-induced MPCs in BMSCs, and anti-TNF Ab reduced INSL6 expression by macrophages in vitro and in TNF-Tg mice in vivo. We conclude that TPMs produce INSL6 to stimulate bone formation and anti-TNF Ab blocks not only enhanced bone resorption but also the anabolic effect of TPMs on bone, limiting its effect to increase bone mass in this model of RA. \u00a9 2021 American Society for Bone and Mineral Research (ASBMR).<\/jats:p>","DOI":"10.1002\/jbmr.4447","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T09:25:05Z","timestamp":1632907505000},"page":"2426-2439","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["TNF-Polarized Macrophages Produce Insulin-like 6 Peptide to Stimulate Bone Formation in Rheumatoid Arthritis in Mice"],"prefix":"10.1093","volume":"36","author":[{"given":"Xiangjiao","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Musculoskeletal Research University of Rochester Medical Center Rochester NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Musculoskeletal Research University of Rochester Medical Center Rochester NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Mark","family":"Kenney","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Musculoskeletal Research University of Rochester Medical Center Rochester NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Musculoskeletal Research University of Rochester Medical Center Rochester NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Musculoskeletal Research University of Rochester Medical Center Rochester NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4854-9698","authenticated-orcid":false,"given":"Edward","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Center for Musculoskeletal Research University of Rochester Medical Center Rochester NY USA"},{"name":"Department of Pathology and Laboratory Medicine, Center for Musculoskeletal Research University of Rochester Medical Center Rochester NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4664-3648","authenticated-orcid":false,"given":"Zhenqiang","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Musculoskeletal Research University of Rochester Medical Center Rochester NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"2024012713454663500_jbmr4447-bib-0001","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1359\/jbmr.090706","article-title":"Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III","volume":"25","author":"Looker","year":"2010","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4137\/CMAMD.S7773","article-title":"Bone mineral density changes in patients with recent-onset rheumatoid arthritis","volume":"4","author":"Hafez","year":"2011","journal-title":"Clin Med Insight Arthritis Musculoskelet Disord."},{"key":"2024012713454663500_jbmr4447-bib-0003","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/ar67","article-title":"Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications","volume":"2","author":"Goldring","year":"2000","journal-title":"Arthritis Res."},{"key":"2024012713454663500_jbmr4447-bib-0004","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell."},{"key":"2024012713454663500_jbmr4447-bib-0005","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev."},{"key":"2024012713454663500_jbmr4447-bib-0006","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1002\/art.34639","article-title":"Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: implications for insufficiency fracture risk","volume":"64","author":"Takahata","year":"2012","journal-title":"Arthritis Rheum."},{"key":"2024012713454663500_jbmr4447-bib-0007","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00002281-200307000-00013","article-title":"Mechanisms of glucocorticoid-induced osteoporosis","volume":"15","author":"Canalis","year":"2003","journal-title":"Curr Opin Rheumatol."},{"key":"2024012713454663500_jbmr4447-bib-0008","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","article-title":"Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis","volume":"5","author":"Taylor","year":"2009","journal-title":"Nat Rev Rheumatol."},{"key":"2024012713454663500_jbmr4447-bib-0009","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int Immunol."},{"key":"2024012713454663500_jbmr4447-bib-0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/BOR.0b013e328356d212","article-title":"Effects of anti-tumor necrosis factor alpha agents on bone","volume":"24","author":"Kawai","year":"2012","journal-title":"Curr Opin Rheumatol."},{"key":"2024012713454663500_jbmr4447-bib-0011","first-page":"280","article-title":"Does anti-TNF-alpha have a role in the treatment of osteoporosis?","volume":"66","author":"McMahon","year":"2008","journal-title":"Bull NYU Hosp Jt Dis."},{"key":"2024012713454663500_jbmr4447-bib-0012","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2012-202698","article-title":"Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8\u2009years in patients with ankylosing spondylitis","volume":"73","author":"Baraliakos","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"2024012713454663500_jbmr4447-bib-0013","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/jbmr.3684","article-title":"Long-term treatment with TNF-alpha inhibitors improves bone mineral density but not vertebral fracture progression in ankylosing spondylitis","volume":"34","author":"Beek","year":"2019","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0014","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00296-019-04418-1","article-title":"Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study","volume":"40","author":"Lee","year":"2020","journal-title":"Rheumatol Int."},{"key":"2024012713454663500_jbmr4447-bib-0015","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00223-016-0114-x","article-title":"Short-term effects of TNF inhibitors on bone turnover markers and bone mineral density in rheumatoid arthritis","volume":"98","author":"Orsolini","year":"2016","journal-title":"Calcif Tissue Int."},{"key":"2024012713454663500_jbmr4447-bib-0016","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/ard.2003.016253","article-title":"Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density","volume":"63","author":"Lodder","year":"2004","journal-title":"Ann Rheum Dis."},{"key":"2024012713454663500_jbmr4447-bib-0017","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J."},{"key":"2024012713454663500_jbmr4447-bib-0018","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1172\/JCI38716","article-title":"NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism","volume":"119","author":"Yao","year":"2009","journal-title":"J Clin Invest."},{"key":"2024012713454663500_jbmr4447-bib-0019","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.40047","article-title":"Brief report: treatment of tumor necrosis factor-transgenic mice with anti-tumor necrosis factor restores lymphatic contractions, repairs lymphatic vessels, and may increase monocyte\/macrophage egress","volume":"69","author":"Bouta","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"2024012713454663500_jbmr4447-bib-0020","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jbmr.2108","article-title":"NF-kappaB RelB negatively regulates osteoblast differentiation and bone formation","volume":"29","author":"Yao","year":"2014","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0021","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0022","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0023","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40364-017-0097-4","article-title":"Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives","volume":"5","author":"Kuo","year":"2017","journal-title":"Biomark Res."},{"key":"2024012713454663500_jbmr4447-bib-0024","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/s41467-019-10677-0","article-title":"TGFbeta-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis","volume":"10","author":"Li","year":"2019","journal-title":"Nat Commun."},{"key":"2024012713454663500_jbmr4447-bib-0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2024012713454663500_jbmr4447-bib-0026","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13075-019-2039-z","article-title":"iNOS dependent and independent phases of lymph node expansion in mice with TNF-induced inflammatory-erosive arthritis","volume":"21","author":"Bell","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"2024012713454663500_jbmr4447-bib-0027","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"2024012713454663500_jbmr4447-bib-0028","doi-asserted-by":"crossref","first-page":"e0135728","DOI":"10.1371\/journal.pone.0135728","article-title":"TNF induction of NF-kappaB RelB enhances RANKL-induced osteoclastogenesis by promoting inflammatory macrophage differentiation but also limits it through suppression of NFATc1 expression","volume":"10","author":"Zhao","year":"2015","journal-title":"PloS One."},{"key":"2024012713454663500_jbmr4447-bib-0029","doi-asserted-by":"crossref","first-page":"e0145342","DOI":"10.1371\/journal.pone.0145342","article-title":"Novel markers to delineate murine M1 and M2 macrophages","volume":"10","author":"Jablonski","year":"2015","journal-title":"PloS One."},{"key":"2024012713454663500_jbmr4447-bib-0030","doi-asserted-by":"crossref","first-page":"11846","DOI":"10.1074\/jbc.M512624200","article-title":"Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression","volume":"281","author":"Yao","year":"2006","journal-title":"J Biol Chem."},{"key":"2024012713454663500_jbmr4447-bib-0031","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bone.2014.01.019","article-title":"Jagged1 is essential for osteoblast development during maxillary ossification","volume":"62","author":"Hill","year":"2014","journal-title":"Bone."},{"key":"2024012713454663500_jbmr4447-bib-0032","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/jbmr.3106","article-title":"The notch ligand Jagged1 regulates the osteoblastic lineage by maintaining the osteoprogenitor pool","volume":"32","author":"Lawal","year":"2017","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0033","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1038\/s41598-020-64018-z","article-title":"The IAP antagonist SM-164 eliminates triple-negative breast cancer metastasis to bone and lung in mice","volume":"10","author":"Lei","year":"2020","journal-title":"Sci Rep."},{"key":"2024012713454663500_jbmr4447-bib-0034","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1074\/jbc.M116.771816","article-title":"RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors","volume":"292","author":"Yao","year":"2017","journal-title":"J Biol Chem."},{"key":"2024012713454663500_jbmr4447-bib-0035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopha.2018.03.080","article-title":"TNF-alpha contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation","volume":"102","author":"Zha","year":"2018","journal-title":"Biomed Pharmacother."},{"key":"2024012713454663500_jbmr4447-bib-0036","doi-asserted-by":"crossref","first-page":"13960","DOI":"10.1073\/pnas.251534698","article-title":"Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo","volume":"98","author":"Roggia","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2024012713454663500_jbmr4447-bib-0037","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-4933-2-14","article-title":"Osteoporosis, inflammation and ageing","volume":"2","author":"Ginaldi","year":"2005","journal-title":"Immun Age."},{"key":"2024012713454663500_jbmr4447-bib-0038","first-page":"1693","article-title":"Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment","volume":"79","author":"Garnero","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"key":"2024012713454663500_jbmr4447-bib-0039","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jbmr.5650050402","article-title":"Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels","volume":"5","author":"Eriksen","year":"1990","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-11-0132","article-title":"Osteoblasts in osteoporosis: past, emerging, and future anabolic targets","volume":"165","author":"Marie","year":"2011","journal-title":"Eur J Endocrinol."},{"key":"2024012713454663500_jbmr4447-bib-0042","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1074\/jbc.M509430200","article-title":"Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts","volume":"281","author":"Kaneki","year":"2006","journal-title":"J Biol Chem."},{"key":"2024012713454663500_jbmr4447-bib-0043","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J Clin Invest."},{"key":"2024012713454663500_jbmr4447-bib-0044","doi-asserted-by":"crossref","first-page":"18245","DOI":"10.1074\/jbc.M610701200","article-title":"NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1","volume":"282","author":"Yamashita","year":"2007","journal-title":"J Biol Chem."},{"key":"2024012713454663500_jbmr4447-bib-0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bone.2009.04.252","article-title":"TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway","volume":"45","author":"Hess","year":"2009","journal-title":"Bone."},{"key":"2024012713454663500_jbmr4447-bib-0046","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1359\/jbmr.070121","article-title":"Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB","volume":"22","author":"Li","year":"2007","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0047","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1073\/pnas.1018501108","article-title":"TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells","volume":"108","author":"Glass","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2024012713454663500_jbmr4447-bib-0048","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.gene.2015.10.065","article-title":"Jagged1 (JAG1): structure, expression, and disease associations","volume":"576","author":"Grochowski","year":"2016","journal-title":"Gene."},{"key":"2024012713454663500_jbmr4447-bib-0049","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.imlet.2020.04.010","article-title":"Notch receptors and ligands in inflammatory arthritis\u2014a systematic review","volume":"223","author":"Sucur","year":"2020","journal-title":"Immunol Lett."},{"key":"2024012713454663500_jbmr4447-bib-0050","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1095\/biolreprod62.6.1593","article-title":"Identification of INSL6, a new member of the insulin family that is expressed in the testis of the human and rat","volume":"62","author":"Lok","year":"2000","journal-title":"Biol Reprod."},{"key":"2024012713454663500_jbmr4447-bib-0051","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1210\/en.2009-0201","article-title":"Inactivation of insulin-like factor 6 disrupts the progression of spermatogenesis at late meiotic prophase","volume":"150","author":"Burnicka-Turek","year":"2009","journal-title":"Endocrinology."},{"key":"2024012713454663500_jbmr4447-bib-0052","doi-asserted-by":"crossref","first-page":"e008441","DOI":"10.1161\/JAHA.117.008441","article-title":"Relaxin family member insulin-like peptide 6 ameliorates cardiac fibrosis and prevents cardiac remodeling in murine heart failure models","volume":"7","author":"Maruyama","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"2024012713454663500_jbmr4447-bib-0053","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.joca.2004.03.003","article-title":"Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis","volume":"12","author":"Blom","year":"2004","journal-title":"Osteoarthr Cartil."},{"key":"2024012713454663500_jbmr4447-bib-0054","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S8756-3282(01)00638-X","article-title":"Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2","volume":"30","author":"Champagne","year":"2002","journal-title":"Bone."},{"key":"2024012713454663500_jbmr4447-bib-0055","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4049\/jimmunol.181.2.1232","article-title":"Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo","volume":"181","author":"Chang","year":"2008","journal-title":"J Immunol."},{"key":"2024012713454663500_jbmr4447-bib-0056","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/jbmr.354","article-title":"Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model","volume":"26","author":"Alexander","year":"2011","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0057","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.1791","article-title":"Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis","volume":"10","author":"Murai","year":"2009","journal-title":"Nat Immunol."},{"key":"2024012713454663500_jbmr4447-bib-0058","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/sji.12162","article-title":"An optimized protocol for human M2 macrophages using M-CSF and IL-4\/IL-10\/TGF-beta yields a dominant immunosuppressive phenotype","volume":"79","author":"Mia","year":"2014","journal-title":"Scand J Immunol."},{"key":"2024012713454663500_jbmr4447-bib-0059","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF03347799","article-title":"Interleukin-4 as a bone regulatory factor: effects on murine osteoblast-like cells","volume":"18","author":"Riancho","year":"1995","journal-title":"J Endocrinol Invest."},{"key":"2024012713454663500_jbmr4447-bib-0060","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1172\/JCI75005","article-title":"Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression","volume":"127","author":"Rahman","year":"2017","journal-title":"J Clin Invest."},{"key":"2024012713454663500_jbmr4447-bib-0061","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3389\/fimmu.2018.01593","article-title":"CD38 is robustly induced in human macrophages and monocytes in inflammatory conditions","volume":"9","author":"Amici","year":"2018","journal-title":"Front Immunol."},{"key":"2024012713454663500_jbmr4447-bib-0062","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1210\/en.2002-220597","article-title":"Inducible nitric oxide synthase mediates bone loss in ovariectomized mice","volume":"144","author":"Cuzzocrea","year":"2003","journal-title":"Endocrinology."},{"key":"2024012713454663500_jbmr4447-bib-0063","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1002\/1529-0131(200112)44:12<2790::AID-ART466>3.0.CO;2-X","article-title":"Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis","volume":"44","author":"Armour","year":"2001","journal-title":"Arthritis Rheum."},{"key":"2024012713454663500_jbmr4447-bib-0064","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/8756-3282(95)00113-R","article-title":"The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate\u2014is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?","volume":"16","author":"Delmas","year":"1995","journal-title":"Bone."},{"key":"2024012713454663500_jbmr4447-bib-0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0066","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jbmr.251","article-title":"Effects of denosumab on bone turnover markers in postmenopausal osteoporosis","volume":"26","author":"Eastell","year":"2011","journal-title":"J Bone Miner Res."},{"key":"2024012713454663500_jbmr4447-bib-0067","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/TCRM.S156350","article-title":"Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis","volume":"14","author":"Suzuki","year":"2018","journal-title":"Ther Clin Risk Manag."},{"key":"2024012713454663500_jbmr4447-bib-0068","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s40266-019-00714-4","article-title":"Pharmacological management of osteoporosis in rheumatoid arthritis patients: a review of the literature and practical guide","volume":"36","author":"Raterman","year":"2019","journal-title":"Drugs Aging."},{"key":"2024012713454663500_jbmr4447-bib-0069","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3899\/jrheum.100829","article-title":"Relationship of focal erosions, bone mineral density, and parathyroid hormone in rheumatoid arthritis","volume":"38","author":"Rossini","year":"2011","journal-title":"J Rheumatol."},{"key":"2024012713454663500_jbmr4447-bib-0070","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/art.40156","article-title":"Effects of teriparatide on joint erosions in rheumatoid arthritis: a randomized controlled trial","volume":"69","author":"Solomon","year":"2017","journal-title":"Arthritis Rheumatol."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.4447","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.4447","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/36\/12\/2426\/55453771\/jbmr4447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/36\/12\/2426\/55453771\/jbmr4447.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:08:05Z","timestamp":1710328085000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/36\/12\/2426-2439\/7516487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":70,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,9,29]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4447","relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBMR.4447\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4447\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4447\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4447\/v4\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4447\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4447\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4447\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4447\/v2\/review1","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2021-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}